To study the effect of swetasarshapa oil nasya on anxiety.

Not yet recruiting

Conditions: Other specified anxiety disorders. Ayurveda Condition: MANOVAHASROTODUSHTIH,

Registration Number: CTRI/2024/01/062027

Lead Sponsor: Dr Pankaj P Surve

Brief Summary: The Study includes two groups Trial Group and ComparisonGroup.

**Trial group:**

The patients Shall be given Nasya of trialdrug Oil and Chlordiazepoxide (Cap. Librium 10mg) for 45 days.The Dose of Nasyaoil shall be in the form of marshyanasya 3ml to 5 ml in each nostril as per body constituents (Prakruti) for 7days and from 8th day onwards patients shall be given 1ml of pratimarshya nasya till 45th dayand Cap. Librium orally 10mg twice a day for total duration of 45 days.

**Comparison Group (Group-II) :**

The patients Shall be given Chlordiazepoxide(Cap.Librium 10mg) twice a day for duration of 45 days.

Route of administration: Nasal route fortrial drug. And Oral route for Cap.Librium for Comparison Group.

Outcome: The Trial drugs shall behelpful for reducing the signs and symptoms of the patient of Anxiety Neurosis.

Primary outcome will be the clinicalparameters observed during study using scale used of HAM-A.

Duration of Study: Total Duration ofStudy will be 45 days.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 94

Inclusion Criteria

Pre-diagnosed case of Anxiety neurosis No discrimination of sex, race, caste and religion Onset between 8 weeks and 2years Subjects with known standard care of treatment Subjects with history of Diabetes mellitus type 2 and mild Hypertension.

Exclusion Criteria

Diagnosed cases of Schizophrenia Subjects showing repeated Panic attack Subjects diagnosed as Medication-induced anxiety disorder, panic disorders, Post traumatic Stress Disorder Subjects having Specific phobia, Agoraphobia or any other chronic systemic disease as Irritable Bowel Syndrome Severe Kidney Disease Pregnant and Lactating women.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reductions in symptoms HAMA Scale of Anxiety	0th day, 8th day, 15th days amd 45thday

Secondary Outcome Measures

Name	Time	Method
reduction in symptoms of anxiety	after 45 days

Trial Locations

Locations (1): CSMSS Ayurved Mahavidyalaya and Hospital
🇮🇳
Aurangabad, MAHARASHTRA, India
CSMSS Ayurved Mahavidyalaya and Hospital
🇮🇳Aurangabad, MAHARASHTRA, India
dr Pankaj Surve
Principal investigator
84446211662
dr.pankajps@gmail.com